ATULBSEATUL LTDMediumNeutral
Announced Mon, 20 Jul · 17:27 IST

Senior management reshuffle in Pharma and Technology

Management Changes View source PDF

ATUL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.8%1-day move
₹6092.00
prior close
₹6100.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.3+1.3+1.4+2.1+0.8+0.9+6.5+11.2
Up moveDown movePending
AI summary

Atul Ltd announced changes in its senior management effective July 18, 2026. Dr Prabhakar Chebiyyam, President of Pharmaceuticals, retired and Dr Dhaval Vashi, associated with the company since December 2022 with 22 years of experience in business development and a doctorate in synthetic organic chemistry, took over as Senior Vice President, Pharmaceuticals. Additionally, Mr Vinay Desai, Executive Vice President, Technology and Manufacturing, joined the senior management team. He has 35 years of manufacturing and technology experience and has been with the company since December 2022.

Likely market impact

Routine senior management succession with internal appointees, no board or KMP change, likely neutral for shareholders.